β-catenin clinical trials at UCSF

1 research study open to eligible people

î²-catenin is a protein in cells that helps control their behavior. UCSF is conducting studies of an experimental drug for adults with advanced solid tumors. UCSF is tracking safety and collecting data on effects.

FOG-001 in Locally Advanced or Metastatic Solid Tumors
open to eligible people ages 18 years and up
The goal of this clinical trial is to determine if FOG-001 is safe and effective in participants with locally advanced or metastatic cancer.
San Francisco, California and other locations

Last updated: January 8, 2026